In multivariable analyses adjusting for MYCN amplification, tumor histology, and INSS stage, Hispanic patients had significantly inferior OS (HR, 1.78, 95% CI, 1.25-2.53; P = .01) compared with White patients (Table 2). The gene discussed is MYCN; the disease is neoplasm.